{"symbol":"BSX","fiscalQuarter":"Q4-2025","reportDate":"2026-02-04","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q4-2025","postBrief":{"headline":"Boston Scientific Beats on EPS, Stock Down 17.6%","keyNumbers":[{"metric":"EPS","actual":"$0.80","expected":"N/A","surprise":"+2.96%"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["We are navigating a challenging market environment.","Our focus remains on innovation and operational efficiency."],"summary":"Management expressed concerns about current market conditions impacting growth. They emphasized a commitment to innovation and efficiency."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Boston Scientific's earnings report showed a small beat on EPS, but the stock dropped significantly by 17.6%. This decline may be attributed to broader market concerns and the lack of revenue data, which leaves investors uncertain about the company's growth trajectory. The management's defensive tone suggests they are facing challenges ahead, which could further impact investor sentiment.","metaDescription":"Boston Scientific (BSX) Q4 2025 earnings: EPS beat by 2.96%. Stock down 17.6%. Full breakdown."}}